GlassScriptPhysician profile
Timothy Gillum
NPI 1316994791
$5,760.20
in general payments reported to CMS, 2019-2025
18 companies · $2,525 in 2025
The $2,525 reported for 2025 was more than what 95% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $267 · 2020: $535 · 2021: $367 · 2022: $492 · 2023: $630 · 2024: $944 · 2025: $2,525.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,188 · Travel and Lodging: $1,912.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,188.13 |
| Travel and Lodging | $1,911.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,994.79 | 2025 | |
| Aerin Medical INC. | $1,801.29 | 2020-2025 | |
| Spirair, INC. | $873.78 | 2024-2025 | Septalign |
| Acclarent, INC | $225.98 | 2020-2024 | Relieva Spinplus, Trudi Nav Cable |
| Optinose US, INC. | $213.08 | 2019-2021 | |
| Endo Pharmaceuticals INC. | $150.15 | 2019-2020 | |
| Abbvie INC. | $76.32 | 2020-2024 | |
| Integra Lifesciences Corporation | $71.75 | 2024 | Trudi Probe, Inspira Air, Acclarent Aera |
| Inspire Medical Systems, INC. | $57.73 | 2023-2024 | Inspire |
| Stryker Corporation | $53.94 | 2021-2024 | Scopis Ent |
| Neurent Medical Limited | $47.74 | 2024 | Neuromark Device, Neuromark Radiofrequency Console |
| Bard Peripheral Vascular, INC. | $43.22 | 2020 | |
| Genzyme Corporation | $39.78 | 2021 | |
| Zimmer Biomet Holdings, INC. | $33.95 | 2019-2025 | Traumaone |
| Depuy Synthes Sales INC. | $33.50 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $16.15 | 2019 | |
| Kaleo, INC. | $14.94 | 2022 | |
| Merck Sharp & Dohme LLC | $12.11 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Gillum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.